Bluesky Facebook Reddit Email

Beta blockers reduce death risk in patients with heart failure initiating dialysis

09.30.20 | National Kidney Foundation

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

Beta blockers may reduce mortality in patients with heart and kidney failure. Among 3,503 patients with heart failure initiating dialysis, 60.4% were receiving beta blockers at time of dialysis initiation; 455 died within 6 months. Compared to non-use, beta blocker use was associated with a 21% lower risk of death within 6 months of dialysis initiation after propensity score matching. These findings support use of beta blockers for patients with heart failure initiating dialysis.

###

ARTICLE TITLE: Beta Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis

AUTHORS: Hui Zhou, John J. Sim, Jiaxiao Shi, Sally F. Shaw, Ming-Sum Lee, Jonathan R. Neyer, Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, and Steven J. Jacobsen

DOI: 10.1053/j.ajkd.2020.07.023

Under embargo until 3pm ET on September 30, 2020. Full text of article available by email from media contact.

American Journal of Kidney Diseases

10.1053/j.ajkd.2020.07.023

Keywords

Article Information

Contact Information

How to Cite This Article

APA:
National Kidney Foundation. (2020, September 30). Beta blockers reduce death risk in patients with heart failure initiating dialysis. Brightsurf News. https://www.brightsurf.com/news/LKNKZXWL/beta-blockers-reduce-death-risk-in-patients-with-heart-failure-initiating-dialysis.html
MLA:
"Beta blockers reduce death risk in patients with heart failure initiating dialysis." Brightsurf News, Sep. 30 2020, https://www.brightsurf.com/news/LKNKZXWL/beta-blockers-reduce-death-risk-in-patients-with-heart-failure-initiating-dialysis.html.